Trials / Conditions / Neoplasms, Plasma Cell
Neoplasms, Plasma Cell
6 registered clinical trials studyying Neoplasms, Plasma Cell — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety, PK/PD of (OriCAR-017) in Subjects With RR/MM - RIGEL Study NCT06271252 | OriCell Therapeutics Co., Ltd. | Phase 1 |
| Not Yet Recruiting | A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma NCT05581875 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Unknown | A Phase 2 Study of Isatuximab in Combination With Pomalidomide and Dexamethasone in MM Patients Who Received O NCT05298683 | Hellenic Society of Hematology | Phase 2 |
| Unknown | A Study to Investigate the Safety and Clinical Activity of Belantamab Mafodotin in Combination With Daratumuma NCT05280275 | Hellenic Society of Hematology | Phase 1 / Phase 2 |
| Unknown | A Phase 2 Study of Isatuximab in Combination With Bortezomib, Cyclophosphamide and Dexamethasone Followed by I NCT05147493 | Hellenic Society of Hematology | Phase 2 |
| Completed | A Study of Ninlaro in Real World Clinical Practice in China NCT04328662 | Takeda | — |